Tempus AI Net Change in Property, Plant, and Equipment 2023-2025 | TEM
- Tempus AI net change in property, plant, and equipment for the quarter ending March 31, 2025 was $-0.003B, a 44.79% decline year-over-year.
- Tempus AI net change in property, plant, and equipment for the twelve months ending March 31, 2025 was $-0.054B, a 39.26% decline year-over-year.
- Tempus AI annual net change in property, plant, and equipment for 2024 was $-0.022B, a 36.08% decline from 2023.
- Tempus AI annual net change in property, plant, and equipment for 2023 was $-0.035B, a 88.32% increase from 2022.
- Tempus AI annual net change in property, plant, and equipment for 2022 was $-0.018B, a 0% decline from .
Tempus AI Annual Net Change in Property, Plant, and Equipment (Millions of US $) |
|
---|---|
2024 | $-22 |
2023 | $-35 |
2022 | $-18 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $10.012B | $0.693B |
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $38.234B | 52.81 |
Hims & Hers Health (HIMS) | United States | $12.982B | 134.88 |
IRhythm Technologies (IRTC) | United States | $4.465B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.309B | 67.32 |
Privia Health (PRVA) | United States | $2.902B | 198.33 |
Enovis (ENOV) | United States | $1.848B | 10.30 |
Clover Health Investments (CLOV) | United States | $1.791B | 0.00 |
Schrodinger (SDGR) | United States | $1.498B | 0.00 |
Phreesia (PHR) | United States | $1.456B | 0.00 |
Omnicell (OMCL) | United States | $1.281B | 22.59 |
Azenta (AZTA) | United States | $1.258B | 58.47 |
10x Genomics (TXG) | United States | $1.024B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
Butterfly Network (BFLY) | United States | $0.534B | 0.00 |
Talkspace (TALK) | United States | $0.486B | 145.25 |
Veradigm (MDRX) | United States | $0.476B | 0.00 |
Claritev (CTEV) | United States | $0.473B | 0.00 |
Standard BioTools (LAB) | United States | $0.395B | 0.00 |
TruBridge (TBRG) | United States | $0.363B | 805.00 |
Nyxoah SA (NYXH) | Belgium | $0.274B | 0.00 |
Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.141B | 0.00 |
Pulmonx (LUNG) | United States | $0.126B | 0.00 |
American Well (AMWL) | United States | $0.116B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
CareCloud (CCLD) | United States | $0.086B | 3.27 |
111 (YI) | China | $0.067B | 0.00 |
Outset Medical (OM) | United States | $0.067B | 0.00 |
P3 Health Partners (PIII) | United States | $0.056B | 0.00 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.051B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
Zhongchao (ZCMD) | China | $0.033B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Precipio (PRPO) | United States | $0.015B | 0.00 |
MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |